Schonfeld Strategic Advisors LLC Atreca, Inc. Call Options Transaction History
Schonfeld Strategic Advisors LLC
- $14.6 Billion
- Q2 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding BCEL
# of Institutions
2Shares Held
30.6KCall Options Held
0Put Options Held
0About Atreca, Inc.
- Ticker BCEL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 31,876,000
- Description
- Atreca, Inc., a clinical-stage biopharmaceutical company, discovers and develops antibody-based immunotherapeutics to treat a range of solid tumor types. Its lead product candidate is ATRC-101, a monoclonal antibody with a novel mechanism of action and target derived from an antibody identified using its discovery platform. The company's ATRC-10...